• Marek Stepniak appointed as new CEO, effective early March 2025
• Marek has extensive experience in the healthcare sector, including leading hospital groups and health technology organisations
• Tim Kelsey, the retiring CEO, will remain with Beamtree as a part-time senior advisor

Beamtree Holdings Limited ('Beamtree' or 'the Company') (ASX:BMT), a leading provider of AI decision support and data insights solutions, has announced the appointment of Marek Stepniak as the new Chief Executive Officer, effective early March 2025. Marek brings a wealth of experience in the healthcare sector, having worked in over 30 countries, including the Middle East, Europe, Asia, and North America. His extensive background includes leading hospital groups and health technology organisations, as well as serving as a healthcare partner at McKinsey & Company. Marek, who has been with Beamtree for the past 18 months as Chief Growth Officer, has been instrumental in spearheading Beamtree's successful expansion into international markets in the Middle East, United Kingdom, and Canada with the broader executive team in winning recent customers. Tim Kelsey, the retiring CEO, will remain with Beamtree as a part-time senior advisor, supporting business development in international markets. Additionally, Tim will assume the position of Chair of the Global Impact Committee (GIC) starting in March 2025. The GIC is an advisory board that provides advice on strategies and policies, promotes best practice and innovation in health data, and advances the Beamtree mission to mobilise the power of data for a healthier, happier world.

Beamtree reaffirms its strong pipeline and momentum heading into 2025. More detail on new contract wins and the accelerating pipeline will be provided to all shareholders with the release of the half year results on 19 February 2025.